|
End-of-day quote
Palestine Exchange
|
||
| - | - |
|
| 08-13 | Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 06-30 | Jerusalem Pharmaceuticals Announces Board Changes | CI |
| Market Cap | 128M 128M 110M 104M 94.63M 177M 12.07B 178M 1.23B 477M 6.17B 480M 469M 20.28B | P/E 2024 |
13.7x | P/E 2025 | 8.13x |
|---|---|---|---|---|---|
| Enterprise Value | 117M 117M 101M 95M 86.56M 162M 11.04B 163M 1.12B 437M 5.65B 439M 429M 18.55B | EV / Sales 2024 |
1.47x | EV / Sales 2025 | 1.47x |
| Free-Float |
35.74% | Yield 2024 |
2.09% | Yield 2025 | 3.26% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2013-06-30 | |
Mohammed Natour
DFI | Director of Finance/CFO | - | 2020-02-29 |
Lina Masrouji
CTO | Chief Tech/Sci/R&D Officer | - | 1988-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 91 | - | |
Nidal Kamal
BRD | Director/Board Member | - | - |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.81% | +0.14% | +21.37% | +72.78% | 49.06B | ||
| +0.41% | +0.49% | +52.69% | +119.28% | 40.37B | ||
| -0.97% | -3.88% | +13.37% | +84.21% | 12.19B | ||
| -1.28% | -1.78% | -11.64% | +12.58% | 12.08B | ||
| +0.57% | +0.95% | +29.02% | +153.11% | 9.14B | ||
| +0.08% | -4.12% | +24.01% | +43.45% | 7.36B | ||
| -0.04% | -0.04% | +22.68% | +222.92% | 7.35B | ||
| +0.81% | +1.38% | +44.31% | -10.54% | 7.32B | ||
| -1.29% | -1.78% | -40.82% | +14.36% | 5.19B | ||
| Average | -0.28% | -0.33% | +17.22% | +79.13% | 16.67B | |
| Weighted average by Cap. | -0.30% | +0.35% | +26.12% | +86.10% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 39.82M 39.82M 34.35M 32.36M 29.49M 55.11M 3.76B 55.53M 383M 149M 1.92B 150M 146M 6.32B | 48.95M 48.95M 42.22M 39.78M 36.24M 67.74M 4.62B 68.25M 471M 183M 2.36B 184M 180M 7.77B |
| Net income | 5.04M 5.04M 4.35M 4.09M 3.73M 6.97M 476M 7.02M 48.47M 18.81M 243M 18.92M 18.5M 799M | 10.18M 10.18M 8.78M 8.28M 7.54M 14.09M 962M 14.2M 97.98M 38.02M 492M 38.24M 37.4M 1.62B |
| Net Debt | -10.32M -10.32M -8.9M -8.39M -7.64M -14.29M -975M -14.39M -99.31M -38.54M -499M -38.76M -37.91M -1.64B | -10.9M -10.9M -9.4M -8.86M -8.07M -15.08M -1.03B -15.19M -105M -40.69M -526M -40.92M -40.02M -1.73B |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
















